Wall Street Hedge

Wednesday, January 20, 2021
Log in
  • Home
  • Nation & Politics
  • Financial News
  • Technology & Research
  • Lifestyle & Health
    • Latest News
      • Business
      • Nature
      • Science
      • World
      • VA Hospitals Are Still Under Investigation for Suspected Drug Thefts

Pfizer-Hospira strikes $15bn deal to boost generics, biosimilars business

By Leave a Comment

The Pfizer logo is seen at their world headquarters in New York

Pharmaceutical company Pfizer Inc on Wednesday announced an acquisition deal worth nearly USD 15 billion with Hospira Inc in a bid to boost its portfolio of generic injectible drugs and biosimilars, i.e. biotech drugs copies.

Pfizer offered USD 90 a share in cash, a 39 percent premium to the closing stock price of Hospira on Wednesday. On the other hand, Hospira gained 35 percent to reach USD 88 before the bell on Thursday, and Pfizer soared 3.6 percent.

The acquisition deal is the largest for Pfizer since it failed AstraZeneca Plc’s takeover attempt that has rebuffed its USD 118 billion approach in 2014, but has continued to stay as a subject of speculation for takeover.

According to Pfizer, the move has clearly highlighted its commitment for deploying capital and delivering revenue as well as earnings per share growth in the upcoming term. The agreement is likely to add between 10 cents and 12 cents per share to the earnings of Pfizer in the first full year after the closure of deal, the company said.

The latest move will also help in increasing Pfizer’s established drugs business or those medications that are no longer covered by patents.

Hospira is known for manufacturing generic versions of injectible drugs that are largerly used in hospitals. It also sells several biosimilars in the overseas market. The company is also working on developing other biosimilars.

Hospira has sought approval from the US Food and Drug Administration (FDA) for marketing a copy of Remicade, blockbuster arthritis treatment from leading drugmaker Johnson & Johnson.

About USD 17 billion, including debt, is the total enterprise value of the deal with Pfizer

As per a regulatory filing, Hospira faces USD 1.75 billion in outstanding long-term debt as of September 30, 2014.

Notably, the acquisition deal needs green signal from the regulators and shareholders.

 

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Financial News Tagged With: Hospira biosimilars, Hospira biotech drugs, Hospira generic drugs, Hospira Inc, Pfizer Inc, Pfizer-Hospira deal

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Recent Articles

AXA building in Wiesbaden, Germany.

Insurer AXA To Buy XL Group For $15 Billion

By Leave a Comment

New York Stock Exchange on Wall Street.

Wall Street Comes Out Intact As Global Stock Rise

By Leave a Comment

Ryanair profits are up despite threats of pilot strike.

Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

By Leave a Comment

Bitcoin bubble may burst, analysts speculate.

Bitcoin Bubble Shows Signs Of Bursting

By Leave a Comment

One percent amassed 82 percent of the world's fortune last year.

82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

By Leave a Comment

Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

By Leave a Comment

General Electric Laboratory

High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

By Leave a Comment

Cryptocurrency bitcoin coins

Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

By Leave a Comment

Computer circuit board

Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

By Leave a Comment

Thanksgiving dinner

Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

By Leave a Comment

Doctors in surgery

Vermont Is Preparing New Health Care System

By Leave a Comment

Saudi Arabia’s capital city Riyadh

Saudi Arabia Has Just Bought Huge Stake in Uber

By Leave a Comment

No Agreement Yet on the Trans-Pacific Partnership

By Leave a Comment

Samsung Shareholders Approve Deal Which Sees Lee Family Gain More Control

By Leave a Comment

Related Articles

  • AXA building in Wiesbaden, Germany.

    Insurer AXA To Buy XL Group For $15 Billion

  • New York Stock Exchange on Wall Street.

    Wall Street Comes Out Intact As Global Stock Rise

  • Ryanair profits are up despite threats of pilot strike.

    Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

  • Bitcoin bubble may burst, analysts speculate.

    Bitcoin Bubble Shows Signs Of Bursting

  • One percent amassed 82 percent of the world's fortune last year.

    82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

  • Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

    Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

  • General Electric Laboratory

    High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

  • Cryptocurrency bitcoin coins

    Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

  • Computer circuit board

    Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

  • Thanksgiving dinner

    Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

Categories

  • Business
  • Entertainment
  • Financial News
  • Lifestyle & Health
  • Nation & Politics
  • National News
  • Nature
  • Science
  • Technology & Research
  • World

Copyright © 2021 WallStreetHedge.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.